| Value | ₹808.8 Cr |
|---|
BSE filing, NSE: ULTRACEMCO. Summary written from the filing by ALFA Finder's alert engine.
UltraTech Cement Ltd: key numbers
- Share price
- ₹11,045.00
- Market cap
- ₹3,25,473 Cr
- Revenue (annual)
- ₹88,512 Cr
- Net profit (annual)
- ₹8,166 Cr
- P/E (TTM)
- 37.0×Sector 32.2×
- Promoter holding
- 58.48%-0.85% QoQ
- FII holding
- 12.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UltraTech Cement Ltd
All →UltraTech Cement Employee Stock Options
UltraTech Cement granted 3,536 stock options, including 3,220 Options and 316 PSUs, under its 2022 Employee Stock Option and Performance Stock Unit Scheme.
UltraTech Cement Price Movement Clarification
UltraTech Cement clarified that the recent material price movement in its shares is market-driven, confirming no undisclosed information or impending announcements triggered the movement.
UltraTech Cement Debt & Borrowing: ₹460.5 Cr
UltraTech Cement approved a corporate guarantee of up to USD 55 million (approx. ₹460.5 Crore) for UHG Holdings IFSC Private Limited to support its business operations.
- Value
- ₹460.5 Cr
UltraTech Cement Investor Presentation: Key Takeaways
UltraTech reports robust Q2FY27 performance with consolidated revenue of Rs. 23,024 Cr (+18.9% YoY) and PAT of Rs. 1,501 Cr (+21.3% YoY). The company focus remains on aggressive capacity expansion and cost control.
UltraTech Cement Debt & Borrowing: ₹522.5 Cr
UltraTech Cement's board approved a USD 55 mn (₹522.5 Cr) corporate guarantee for associate UHG Holdings IFSC. The contingent liability supports UHG Holdings' business loan.
- Value
- ₹522.5 Cr
UltraTech Cement Management Change
UltrTech Cement's Vice Chairman K.K. Maheshwari steps down w.e.f. January 2027. MD K.C. Jhanwar re-designated as Non-Executive Vice Chairman after his MD term expires.
Other legal & regulatory announcements
All →SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals disclosed that the CIT(Appeals) dismissed its appeal against a ₹7.19 Crore income tax assessment for AY 2018-19. The company is reviewing the order and expects no material impact.
- Value
- ₹7.19 Cr
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals received an Income Tax appellate order allowing its appeal for AY 2023-24. The outstanding tax demand of Rs.45.63 Crore, including interest, stands vacated.
- Value
- ₹45.63 Cr
DPSC Legal & Regulatory
DPSC (India Power Corporation) received NSE and MSE fines for the late FY2026 Annual Report. Total impact is Rs.2.42 lakh; the company plans to seek waiver.
- Value
- ₹0.02 Cr
GSB Finance Legal & Regulatory
Coffers Finvest (formerly GSB Finance) reported SAT disposed of an appeal against one BSE fine, which was withdrawn. The remaining ₹1.20 Lakh fine was paid, leaving no outstanding fines.
- Value
- ₹0.01 Cr
PC Jeweller Legal & Regulatory
SEBI issued administrative warning letters to PC Jeweller's promoter MD and Company Secretary. The warnings concern failure to maintain a structured digital database for a quarterly business update.
Aditya Infotech Legal & Regulatory
Aditya Infotech says ICC arbitration brought by Avathon and SparkCognition was withdrawn after mutual discussions. The company states no material adverse impact on its operations or finances.